Pediatrix Medical Group, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
August 03, 2023 at 06:00 am EDT
Share
Pediatrix Medical Group, Inc. reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported sales was USD 500.58 million compared to USD 486.03 million a year ago. Net income was USD 28.28 million compared to USD 27.14 million a year ago. Diluted earnings per share from continuing operations was USD 0.34 compared to USD 0.36 a year ago. Diluted earnings per share was USD 0.34 compared to USD 0.32 a year ago.
For the six months, sales was USD 991.59 million compared to USD 968.26 million a year ago. Net income was USD 42.49 million compared to USD 5.95 million a year ago. Diluted earnings per share from continuing operations was USD 0.52 compared to USD 0.11 a year ago. Diluted earnings per share was USD 0.52 compared to USD 0.07 a year ago.
Pediatrix Medical Group, Inc. is a provider of physician services, including newborn, maternal-fetal, pediatric cardiology and other pediatric subspecialty care. The Companyâs affiliated clinicians provide services to women, babies and children across the continuum of care, both in hospital settings and office-based practices. Its specialties include obstetrics, maternal-fetal medicine and neonatology, complemented by more than 20 pediatric subspecialties, as well as pediatric primary and urgent care clinics. Its national network comprises over 2,620 affiliated physicians, including 1,330 physicians who provide neonatal clinical care, primarily within hospital-based neonatal intensive care units (NICUs), to babies born prematurely or with medical complications. It has over 580 affiliated physicians who provide maternal-fetal and obstetrical medical care to expectant mothers experiencing complicated pregnancies primarily in areas where its affiliated neonatal physicians practice.